Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyamine biosynthetic enzymes are responsible for the production of polyamines (putrescine, spermidine, and spermine), which are essential for cell growth, proliferation, and various cellular functions. The core enzymes include ornithine decarboxylase, which catalyzes the first and rate-limiting step, as well as S-adenosylmethionine decarboxylase, spermidine synthase, and spermine synthase. These enzymes are tightly regulated, as polyamines play pleiotropic roles in DNA stabilization, gene expression, apoptosis, and protein synthesis. Dysregulation of polyamine biosynthesis contributes to several diseases, particularly cancers and proliferative disorders, making these enzymes important therapeutic targets. Pharmacological inhibitors of polyamine biosynthetic enzymes, such as DFMO, are being studied and used in clinical contexts to limit pathological cell growth[1][2][4][5][6][7][8].
Enzyme inhibition (e.g., blocking ODC impairs cell proliferation by depleting polyamines); Induction of apoptosis via modulation of polyamine levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyamine biosynthetic enzyme.